Noncompetitive functional inhibition at diverse, human nicotinic acetylcholine receptor subtypes by Bupropion, phencyclidine, and ibogaine.
Noncompetitive functional inhibition at diverse, human nicotinic acetylcholine receptor subtypes by bupropion, phencyclidine, and ibogaine.